MATTHEW BATTAGLIA: Open Payments
NPI 1972818227 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,357 in 37 payments from 9 companies in 2025. Trend: 2023 $333 · 2024 $431 · 2025 $3,357
Speaker / faculty: $1,625Food & beverage: $1,432Consulting: $300
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $2,422 |
| Alkermes, Inc. | 6 | $401 |
| E.R. Squibb & Sons, L.L.C. | 5 | $211 |
| Supernus Pharmaceuticals, Inc. | 4 | $176 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Orexo US, Inc. | 1 | $22 |
| Indivior Inc. | 1 | $17 |
Products named: VRAYLAR, ARISTADA, COBENFY, Qelbree, LYBALVI, SPRAVATO, ABILIFY ASIMTUFII, FANAPT.
Industry payments across CO — which companies pay providers there.
